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Abstract 
Throughout the United States, the use of the cardiopulmonary bypass (CPB) machine 
during cardiac surgery has become a widely employed practice. Although this machine 
has simplified cardiac surgery by allowing the heart to be stopped, the technology also 
causes adverse effects on a patient’s body and cognitive functions. These include 
complications of the inflammatory system, heart, lungs, kidneys, and brain. Using the 
CPB can not only cause physical harm, but it can also lead to cognitive decline that can 
affect the patient’s quality of life. Studying the CPB in terms of its adverse effects is 
imperative to making any effort to diminish the complications. Evidence-based research 
shows that methods utilizing equipment such as a membrane oxygenator, heparin-coated 
circuits, and ultrafiltration, as well as several medications may reduce the negative 
physical and neurocognitive outcomes. 
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The Adverse Effects of the Cardiopulmonary Bypass Machine 
The human heart is a miraculous organ. It is continuously, involuntarily pumping 
blood so that every muscle, every artery, and every cell in one’s body can get the oxygen 
it requires. However, sometimes this process does not work as it should and the body 
does not adequately receive the blood, and consequently the oxygen, it needs. This is 
oftentimes due to a blockage in one or more of the coronary arteries, the vessels carrying 
blood to the heart itself. If the heart is not getting enough blood, it is not getting enough 
oxygen. Therefore, the heart may infarct and portions of the heart may begin to die. 
When some of the cardiac tissue dies, the heart’s pumping ability is decreased which 
further continues the cycle of inadequate blood supply. Scenarios such as this one need to 
be corrected immediately. 
 Blockages in the heart are often corrected with coronary artery bypass graft 
surgery while the heart is on the cardiopulmonary bypass (CPB) machine (Lewis, 
Heitkemper, Dirksen, O’Brien, & Bucher, 2007). While the use of this machine during 
the surgery has been beneficial in stopping the heart for surgery, it poses many physical, 
emotional, and cognitive risks that could possibly lead to a diminished quality of life and 
on the rare occasion, death. Each of these negative outcomes will be further discussed. 
The Cardiopulmonary Bypass Machine and How it Works 
The CPB is the machine that allows surgeons to operate on a nonmoving, 
bloodless heart. It allows the heart to be stopped so that it can be cut open and the 
blockage can be corrected. This machine is the main component in a type of circulation 
known as extracorporeal circulation, or circulation that takes place outside of the body. 
Blood normally enters the heart in the right atrium and travels just below that to the right 
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ventricle. From there the blood exits the heart into the lungs where carbon dioxide is 
taken out of the blood and replaced with oxygen. After traveling through the lungs, the 
blood is sent back into the heart in the left atrium, enters into the left ventricle, and from 
there is injected into the aorta where it travels to the rest of the body. The 
cardiopulmonary bypass does nearly the same incredible process, outside of the body, in 
a machine (Hessel & Edmunds, 2003). 
Stilling the Heart 
In order to use the CPB, the heart must be stopped. Cardiac surgery with CPB 
cannot occur if the heart is still beating. Cardioplegia is the act of stopping the heart so a 
surgeon can operate on it. This process is done by using a solution composed of eight to 
twenty mEq/L of potassium, magnesium, and other components (Hessel & Edmunds, 
2003). This solution may be injected into the aortic root (portion of the body’s main 
artery that is connected with the heart) that is proximal to the clamp. Using this method 
will allow the solution to enter only the heart and not travel systemically. When the 
solution is injected into the aortic root it is known as antegrade; inserting it into the 
coronary sinuses is called retrograde. This mixture will arrest the heart during diastole 
within 30 to 60 seconds and may be combined with either a crystalloid solution or blood 
(Hessel & Edmunds, 2003).  
The Use of Hypothermia 
There has been much research and debate on whether or not the patient should be 
placed in a hypothermic state during CPB. Whether warm or cold cardioplegia is used, 
research shows that using a potassium solution will decrease oxygen consumption of the 
heart by 90%, but using a hypothermic state will decrease the oxygen consumption even 
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further by an additional 5% to 20% (Flynn, Adams, & Alligood, 2003). The patient may 
be chilled to a temperature of 25°C-34°C for moderate hypothermia and even less for 
deep hypothermia. Chilling the body showed to reduce oxygen consumption in the heart 
to preserve the muscle, as well as protect neurological function. According to Nussmeier 
(2005), every 1°C that the temperature is lowered, cerebral metabolic rate is decreased by 
7%. Decreasing the metabolic rate lessens the brain’s need for oxygen which helps to 
preserve its function. One particular study found that patients who underwent 
hypothermia to 34°C as opposed to 37°C had a significantly reduced decline in attention 
and dexterity by 55.6% and 41.3% (Nathan, Wells, Munson, & Wozny, 2001). Although 
many benefits to hypothermic cardioplegia have been found, warm cardioplegia has 
shown to be advantageous as well (Flynn et al., 2003). 
How the CPB Works 
 After the heart is stopped, cannulas can either be placed in the superior and 
inferior vena cava or a single cannula can be placed in the right atrium (Hessel & 
Edmunds, 2003). Placing the cannulas in these locations collects the blood before it 
enters into the heart. From there, the blood travels into the venous reservoir. The 
reservoir is a great holding place for up to one to three liters of blood. It also helps to trap 
any venous bubbles and is the site for adding any medications or extra blood if necessary. 
After the reservoir, the blood enters into the membrane oxygenator. This is the vital 
section of the CPB that acts as the lungs of the machine. The membrane oxygenator 
consists of an extremely thin microporous membrane made of either polypropylene or 
silicone rubber. This membrane separates the gases from the blood. Although carbon 
dioxide is diffusible in plasma, oxygen is not and the blood must be spread very thin so 
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the oxygen may diffuse into the blood. Membrane oxygenators add up to 470 mL of 
oxygen and extract 350 mL of carbon dioxide from the blood every minute (Hessel & 
Edmunds, 2003). 
 A heat exchanger is also used in conjunction with the oxygenator. This device is 
typically placed just before the oxygenator because it helps to prevent bubbles from 
forming in the blood. The heat exchanger may be used to either warm or cool the blood 
based on the institution’s policies, but generally the blood is cooled to minimize oxygen 
consumption. Monitoring the temperature of the blood during the operation as well as 
observing the speed and temperature of rewarming afterward is important. Rewarming 
too quickly or to too great a temperature may cause significant problems. It is also 
necessary that the cardioplegia system has its own separate heat exchanger (Hessel & 
Edmunds, 2003). 
 During the surgery and through the use of the CPB, many microemboli are 
produced. These are tiny clots formed either by gases or blood particles. Emboli have 
been found to be the cause of many difficulties following surgery. Because the brain 
receives 14% of cardiac output, it is especially vulnerable to receiving one or more of the 
microemboli which oftentimes lead to stroke (Hessel & Edmunds, 2003). Therefore, the 
CPB must reduce the number of microemboli to decrease the chance of plugging a vessel 
throughout the body. Prevention of microemboli is accomplished through the use of a 
membrane oxygenator, the prevention of air entering the circuit, and the use of a 
microfilter.  Whether the microfilter is a depth filter or a screen filter, it will effectively 
trap microemboli and prevent them from reentering the blood stream (Hessel & 
Edmunds, 2003). 
EFFECTS OF CARDIOPULMONARY BYPASS                                                                 8 
 
 Once the blood is oxygenated and filtered, it enters the body, again bypassing the 
heart completely. A cannula into the ascending aorta is usually the entrance point of 
choice, but the femoral or iliac arteries are options as well. The surgeon may choose to 
use the femoral or iliac arteries if plaque lines the aortic wall. Atherosclerosis in the aorta 
is dangerous, because if pieces of the plaque become dislodged, these pieces may travel 
to the brain and cause a stroke (Hessel & Edmunds, 2003). 
Negative Effects of the Cardiopulmonary Bypass 
Physical Adverse Effects 
 Systemic inflammatory response. When the blood travels through the CPB, it is 
traveling through something much different than its usual familiar environment. Instead 
of traveling through the vessels that it was designed to go through, the blood is now 
flowing through polyvinyl chloride tubing (Hessel & Edmunds, 2003). Although the 
tubing is compatible with blood, blood was obviously not made to travel through the 
tubing. Because the blood is being introduced to this foreign material, it is only natural 
that the body tries to protect itself. Therefore, the systemic inflammatory response 
syndrome (SIRS) often occurs after CPB as the body’s reaction to the new substance. It is 
characterized by the body producing at least two of the following characteristics: 
temperature >38°C or <36°C, heart rate >90 beats per minute, respiratory rate >20 
breaths per minute or PaCO2 < 32 mmHg, or leukocytes >12,000 (Laffey, Boylan, & 
Cheng, 2002).  
 Several factors may account for SIRS in many patients. One of them is the fact 
that the blood comes in contact with the foreign substances of the tubing and the machine 
itself. The second is known as an ischemia-reperfusion injury. Once the aorta is clamped 
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off, organs such as the brain, heart, lungs, and kidneys may not receive adequate 
oxygenation and may therefore experience some ischemia. But once these are reperfused 
when the clamp comes off, studies show that components of the inflammatory response 
are released, contributing to SIRS. Another factor that may indirectly lead to SIRS is the 
release of endotoxins from the abdominal organs after they incur injury. This injury 
occurs because the splanchnic vessels (vessels supplying the abdominal viscera) are 
generally hypoperfused during and after use of CPB (Laffey et al., 2002). Once this 
damage occurs, the endotoxins are released and are thought to be a cause of inflammatory 
response activation (Cremer et al., 1996; Laffey et al., 2002). Other factors not 
specifically noted with CPB that activate the response include surgical trauma, blood 
loss, and hypothermia, all of which also occur during cardiac surgery, leading to greater 
inflammation (Laffey et al., 2002).  
 Once the inflammatory response is activated, the body releases many different 
components. Complement is one of these inflammatory components that consists of 
several different elements. Two of these, C5a and C3a, show to be significantly elevated 
after CPB during a study of the inflammatory process after on-pump cardiac surgery (use 
of CPB) and off-pump (use of beating heart) (Ascione et al., 2000). Cytokines, such as 
tumor necrosis factor (TNF) and several of the interleukins (IL), are also a major 
component of the inflammatory response that may be increased (Laffey et al., 2002). 
When studying the effects of on-pump surgery, it was found that IL-8 increased and 
remained elevated after surgery (Ascione et al., 2000). IL-6 levels were also elevated 
after CPB and again at 3 hours past surgery (Cremer et al, 1996). Other elevated 
inflammatory components due to CPB include monocytes, neutrophil and leukocyte 
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elastase, and white blood cell counts (Ascione et al., 2000; Cremer et al., 1996; Edmunds, 
1998; Laffey et al., 2002). The coagulation-fibrinolytic cascades are also two very 
important responses to inflammation. Certain plasma factors activate during CPB to form 
thrombin which in turn forms an insoluble fibrin clot. This process is pivotal to the 
understanding of how CPB can affect the body. Once the endothelium of a vessel is 
damaged by inflammation, its surface becomes more susceptible to platelet and clot 
adhesion. This has been linked to the progression of atherosclerosis and other 
cardiovascular complications (Laffey et al., 2002). 
 Approximately 20% of low-risk patients develop complications following CPB 
(Laffey et al., 2002). Not only does SIRS damage the blood vessels throughout the body, 
it affects the rest of the body as well. Systemic inflammatory response syndrome is a 
generalized inflammatory process that contributes to multi-organ failure (Laffey et al., 
2002). When inflammatory mediators are elevated, impairment of organ function also 
occurs. A study concludes that inflammation causes the rise in transaminases, urea, 
creatinine, and amylase, which each indicate failure of certain body organs following 
surgery (Cremer et al., 1996).  
 Cardiovascular effects. Although the purpose of using the cardiopulmonary 
bypass is ultimately to correct heart problems, using this machine often leads to other 
adverse cardiovascular effects. These effects may be due to the inflammatory response 
causing aggravation to the heart, or just due to the fact that the heart is being operated on, 
manipulated, often frozen, and changed. One common problem after CPB is that the heart 
develops an arrhythmia which is any abnormal heart rhythm or speed. The most common 
arrhythmia following CPB is atrial fibrillation (AF), which occurs in up to 40-50% of 
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patients (Auer et al., 2005; Gunaydin et al., 2007). Atrial fibrillation is defined as “rapid 
randomized contractions of the atrial myocardium, causing a totally irregular rapid atrial 
rate” (Fibrillation, 2003, p. 672). 
 This arrhythmia that commonly happens within four days of surgery may cause 
hypotension, tachycardia, heart failure, stroke, and other potentially fatal events (Auer et 
al., 2005; Gunaydin et al., 2007). It is not known exactly what causes AF post-CPB, but it 
is probably due to a multitude of factors. One study found that inflammation from SIRS 
plays a direct role in causing atrial fibrillation. Two groups undergoing CPB were 
studied. When the first group underwent cardiac surgery, their cardiopulmonary bypass 
machine was supplied with leukofiltration and the surface of the inside of the machine 
and tubing was modified with a Polymethoxyethylacrylate coating. These are two 
methods thought to reduce the inflammatory response. The second group did not have 
either of these methods, and the CPB was left as it normally is. After surgery, results 
showed that in the first group with the leukofiltration and coating, the inflammatory 
mediators, such as IL-2, C3a, and white blood cells, were significantly lower. Only 10% 
of the first group developed atrial fibrillation whereas 35% of the group with no 
modification developed this arrhythmia. This study shows that inflammation plays a 
significant role in the development of cardiac issues after surgery (Gunaydin et al., 2007). 
While the inflammatory process may play an important role in causing AF, other 
factors may relate to its development. Increased age may be a primary factor. Sixty-nine 
was the median age for those that developed AF, while 64 was the median age for those 
that did not (Auer et al., 2005). This same study found that the type of cardiac surgery 
may be a risk factor. As opposed to a coronary artery bypass graft surgery, the research 
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from this study showed that surgery for valvular heart disease led to a greater number of 
patients with postoperative AF. This may occur because valvular heart surgery often 
requires manipulation of the nerve fibers that cause heart conduction. Any damage to the 
conduction system may increase the likelihood for AF (Auer et al., 2005). Creswell et al 
(2005) researched many studies to find the risk factors for AF. Patients that were placed 
in a mild hypothermic state (34°C) during surgery had fewer incidences of postoperative 
AF than those in moderate hypothermia (28°C). Other factors found in this review that 
are associated with less AF incidences are the use of posterior pericardiotomy and the use 
of heparin-coated circuits (Creswell, Alexander, Ferguson, Lisbon, & Fleisher, 2005).  
The heart may be damaged in other ways besides developing an arrhythmia. 
Using CPB was found to release a greater amount of troponin T within the first 72 hours 
postoperative compared with patients who had beating heart surgery (Khan et al., 2004). 
Troponin T is a cardiac specific protein that is released after myocardial injury. 
Therefore, since the level was elevated even higher after CPB, it shows a greater amount 
of injury to the heart muscle. Another study found that there was moderate biventricular 
dysfunction in nearly every patient immediately after bypass. Based on the patient’s 
preoperative ejection fraction and degree of cardiac dyssynergy (muscular 
incoordination), some patients were able to recover from the biventricular dysfunction 
while others were not (Mangano, 1985).  
Pulmonary dysfunction. Another important finding after CPB is that the lungs 
are also oftentimes negatively affected. Up to 20% of patients after cardiac surgery with 
CPB need to be ventilated for more than 48 hours because of the pulmonary dysfunction 
(Shlensak & Beyersdorf, 2005). Studies have shown that this pulmonary dysfunction is 
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caused by a variety of factors such as inflammation and ischemia (Ng, Wan, Yim, & 
Arift, 2002; Raijmakers et al., 1993; Shlensak & Beyersdorf, 2005). 
The inflammation caused by CPB as discussed earlier plays a role in pulmonary 
dysfunction. This often leads to pulmonary edema and excessive pulmonary secretions 
(Shlensak & Beyersdorf, 2005). One study examined a lung biopsy post-surgery and 
found that the pneumocytes and endothelial cells of the lungs were swollen and necrotic. 
This damage was due to alveolar edema caused by the leakage of neutrophils and 
erythrocytes caused by inflammation. The edema, coupled with the facilitation of 
inflammatory cells and the buildup of alveolar protein, causes decreased lung 
compliance. This reduced compliance is evidenced by an increase in lung permeability, 
an increase in pulmonary vascular resistance, and changes in lung surfactant (Ng, Wan, 
Yim, & Arift, 2002). One study researched the increase in lung permeability caused by 
CPB using the 67Ga-transferrin pulmonary leak index. This study showed that CPB 
causes a pulmonary vascular leak that was identified using 67Ga kinetics. The 
researchers concluded that this leakage may be leading to pulmonary injury as well as the 
increased permeability (Raijmakers et al., 1993).  
This inflammatory process may also rarely cause acute respiratory distress 
syndrome (ARDS). In a study of 3,278 patients undergoing CPB, 13 of them developed 
ARDS that resulted from the toll the inflammation took on the lungs. Although this is 
only 0.4% of the total population, two of those patients died. ARDS is often associated 
with a high mortality rate. In this study it was 15%, but other studies show the mortality 
rate of ARDS after CPB to be between 30-70% (Milot et al, 2001).  
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Ischemia of the lungs can also be a factor leading to pulmonary dysfunction. 
During CPB, the pulmonary artery through which deoxygenated blood enters the lungs is 
oftentimes clamped. This leaves only the bronchial arteries to supply blood to the lungs. 
Studies show that circulation of the bronchial artery (main vessel supplying oxygenated 
blood to the lungs) is greatly reduced during CPB, and this may be causing ischemia of 
the lungs (Shlensak & Beyersdorf, 2005).  
In a separate study, two groups of piglets on CPB were examined. The first group 
was on CPB for 90 minutes and the pulmonary artery was clamped. The second group 
was also on CPB for the same amount of time; however the pulmonary artery was not 
clamped. In the end, both groups showed lung injury. This injury was determined by the 
increase in pulmonary vascular resistance, increased alveolar-arterial oxygen gradients, 
and decreased pulmonary compliance. Although both groups on CPB demonstrated 
pulmonary dysfunction, the first group whose pulmonary artery was clamped showed 
significantly greater damage. This study suggests that partial CPB in which the 
pulmonary artery is not clamped may be a better choice to decrease pulmonary injury 
(Chai et al., 1999). 
One study discovered that CPB alone may not be the cause of the lung injury. It 
may be the result of several factors. These may include general anesthesia, sternotomy, 
violation of the pleura, administration of heparin-protamine, hypothermia, and others 
(Ng, Wan, Yim, & Arift, 2002). In one study, atelectasis, as opposed to vascular lung 
injury, is the main cause of pulmonary dysfunction (Groeneveld, Jansen, & Verheij, 
2007). The authors concluded that the atelectasis was not caused by CPB. The amount of 
pulmonary injury caused by CPB has yet to be determined and is still currently being 
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researched. No conclusive evidence has been found (Groeneveld, Jansen, & Verheij, 
2007). 
Renal complications. The kidneys are very susceptible to injury after cardiac 
surgery with CPB. Up to 30% of these patients using CPB develop acute renal failure 
(ARF) and approximately 1% then requires dialysis (Rosner & Okusa, 2006). This kidney 
injury may then further lead to higher mortality, longer stays in the intensive care unit, 
and a greater risk for infectious complications. The type of cardiac surgery may play an 
integral role in the development of ARF. Combined coronary artery bypass 
grafting/valvular surgery poses the greatest risk for developing ARF (4.6% of patients), 
while typical coronary bypass grafting has the lowest incidence (2.5%; Rosner & Okusa, 
2006). 
Although the main focus of most studies is how the CPB affects renal function, 
Rosner and Okusa stated that most patients who are about to undergo cardiac surgery 
have already sustained minor or major renal insults (Rosner & Okusa, 2006). If the 
patient has had a myocardial infarction, then his left ventricular function was probably 
reduced which in turn minimizes cardiac output and reduces renal perfusion. This and 
other causes of renal injury preoperatively may add to the adverse effects of the CPB.  
Glomerular filtration rate (GFR) is the most important determinant of renal 
function (Sear, 2005). The GFR is oftentimes measured by creatinine clearance. Any 
reduction in GFR below the normal limit illustrates that the kidneys are not functioning 
properly to filter urine. In a study comparing on-pump versus off-pump, the on-pump 
group showed a significant decrease in GFR as demonstrated by a decrease in creatinine 
clearance (Ascione, Lloyd, Underwood, Gomes, & Angelini, 1999). An increase in the 
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albumin-to-creatinine ratio and an increase in N-acetyl glucosaminidase activity in the 
on-pump groups showed renal dysfunction as well. Each of these renal tests shows that 
CPB can be harmful to kidney function. In a separate study comparing on and off-pump 
cardiac surgery, patients undergoing on-pump surgery had more severe cases of acute 
kidney injury (Massoudy et al., 2008). In this particular study, acute kidney injury was 
defined by having an increase in serum creatinine ≥50% or ≥0.3mg/dl within 48 hours. 
Although the off-pump group did show signs of kidney injury, these patients developed it 
less often and had milder cases. The on-pump group also needed more renal replacement 
therapy (Massoudy et al., 2008).  
Many suggestions have been made as to why the kidneys in particular are injured 
during CPB. As with most organs, the inflammatory response plays a role. The study 
comparing on and off-pump patients found the level of C-reactive protein and IL-6 (2 
inflammatory markers) to be increased in the on-pump group. This was the group that 
also had more severe and frequent kidney complications postoperatively. This increase in 
the inflammatory response may be one of the reasons for the injury (Massoudy et al., 
2008). CPB also stimulates several complements, other cytokines, and oxygen free 
radicals. These inflammatory mediators lead to leukocyte extravasation and edema, 
causing kidney injury (Rosner & Okusa, 2006).  
The kidneys receive 20% of cardiac output and are incredibly sensitive to 
hypoperfusion (Sear, 2005). Therefore, when the kidneys are not receiving adequate 
perfusion, cellular injury takes place. These hemodynamic effects play a large part in the 
occurrence of injury (Rosner & Okusa, 2006). Ascione et al. (1999) identified this injury 
with hypoperfusion as well as loss of pulsatile perfusion. Other factors associated with 
EFFECTS OF CARDIOPULMONARY BYPASS                                                                 17 
 
causing renal injury may be emboli that enter renal circulation as well as the effects of 
different vasoactive and nephrotoxic medications (Rosner & Okusa, 2006). A study 
found that preoperative mild dysfunction plays a major role in postoperative 
complications. In this study the following complications were common: increased 
mortality, renal replacement therapy, new onset of atrial fibrillation, and a longer stay in 
the intensive care. Since the kidneys play a large part in ridding the body of waste, any 
injury or failure of these organs will have detrimental effects if not taken care of 
immediately (Ramakrishna et al., 2008). 
Adverse cerebral effects. Although adverse outcomes affecting all bodily organs 
can be very serious, those affecting the brain can be most damaging. Damage to the brain 
is most commonly caused by cerebral emboli (Patel et al., 2002). These may consist of 
atherosclerotic plaque, air, fat, and platelet aggregates (Roach et al., 1996). Other causes 
of brain injury may be hemodynamic fluctuations, cerebral hyperthermia after CPB is 
discontinued, and inflammation. Hypoperfusion with the ischemia/reperfusion cycle to 
the brain may also be another cause of damage (Hogue, Palin, & Arrowsmith, 2006). 
Although membrane oxygenators and arterial line filters help reduce these possible 
causes of injury, neurological adverse effects still occur because of CPB (Carrascal et al., 
1999; Hessel & Edmunds, 2003). 
Whichever the cause, there are several commonly noted cerebral outcomes. One 
certain study characterized the types of injuries into four different categories: persistent 
neurological focal deficits, stupor or coma, temporary neurological focal deficits, and 
seizures (Carrascal et al., 1999). Results from this study showed that 3% (76 patients) 
developed some type of complication. Of this 3%, 13 patients developed persistent 
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neurological focal deficits, 18 had a stupor or coma following CPB, 18 had temporary 
focal deficits, and 27 had a seizure. Twenty-nine percent of these patients died following 
surgery. In a separate study, adverse cerebral outcomes took place in 6.1% of the patients. 
They fell into one of the following categories: focal injury, stupor or coma, deterioration 
in intellectual function, memory deficit, or seizure (Roach et al., 1996).  
When comparing off-pump and on-pump cardiac surgery, there was a 65-fold 
increase in cerebral microemboli produced during on-pump surgery (Bowels et al, 2001). 
Although there was not a significant number of deaths or strokes in this study, this 
massive increase in microemboli helps to show that CPB can very easily present fatal 
problems. In a similar study comparing off-pump and on-pump surgery, 1.6% of on-
pump patients developed a focal neurologic deficit (Patel et al., 2002). These deficits may 
have been aphasia, loss of vision, momoparesis, hemiparesis, or comatose state. 
Compared with the on-pump, off-pump with aortic manipulation had only 0.4% of 
patients develop one of these deficits while off-pump without aortic manipulation had 
0.5% develop one (Patel et al., 2002).  
Although these are not high percentages, each of these studies demonstrates that 
use of CPB leads to an increase in neurological injury. These injuries may not lead to 
death, but they can be debilitating and life-changing. There are several identified risk 
factors: advanced age, prior stroke, systolic hypertension, diabetes, female gender, and 
atherosclerosis of the ascending aorta (Hogue et al., 2006).  
Cognitive Adverse Effects 
 One subject that has varying results is that of adverse cognitive function after 
CPB use. One definition of cognitive decline is a 20% decrease in baseline performance 
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in at least 20% of the main variables such as motor skills, verbal memory capacity, and 
attention (Van Dijk et al., 2002). Cognitive decline can occur in up to three quarters of 
patients after cardiac surgery and continue for six months in a third of these patients 
(Newman et al., 2001a). The causes of this decline are similar to those that cause adverse 
cerebral effects such as a microembolism, inflammation, and hypoperfusion (Newman et 
al., 2001a).  
 In a study of 261 patients who underwent cardiac surgery, 53% of those had 
cognitive decline at discharge, 36% at six weeks, 24% at six months, and 42% at five 
years (Newman et al., 2001b). Cognitive decline in this study was defined as a drop of at 
least one SD in the scores on tests of any one of four domains. A drop of one SD is equal 
to a decline in cognitive function of about 20%. The domains studied are verbal memory 
and language comprehension, abstraction and visuospatial orientation, attention, 
processing speed, concentration, and visual memory. From this same study, the author 
took a different approach and also studied how neurocognitive function affected the 
patients’ quality of life five years after surgery (Newman et al., 2001a). The researchers 
found that cognitive function postoperatively was directly correlated with long-term 
quality of life. When the cognitive function immediately after surgery was reduced, the 
patients generally had lower overall health and were working less productively. Through 
these results, this author believes that this decline in cognitive function may have 
negative financial and social implications (Newman et al., 2001a).  
 The P300 auditory-evoked potentials test measured brain function in a separate 
study (Kilo et al., 2001). This study reflects information processing, alertness, and 
memory updating. When this test was used on patients who used CPB, the P300 was 
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significantly impaired at seven days after surgery. However, this test showed the results 
to be almost normalized at four months. Although this particular test found that cognitive 
function may improve around four months, Newman et al. believes that patients who 
have cognitive decline immediately after surgery are at increased risk for long-term 
decline (Newman et al., 2001b). 
 The problem is that CPB alone may not be the cause for cognitive decline. In a 
study comparing on-pump with off-pump patients, the results for cognitive decline did 
not vary significantly (Van Dijk et al., 2002). At three months postoperatively, cognitive 
decline occurred in 21% of off-pump patients while it occurred in 29% of on-pump. This 
study shows that CPB did have slightly more patients develop cognitive dysfunction, but 
it also occurred in off-pump patients. These findings may demonstrate that CPB might 
not be the main cause. It could be a contributor, but other factors may play a role. 
Whether CPB is the major causative factor or not, this study shows that surgery in 
general may cause adverse cognitive effects. These adverse effects cause a diminished 
quality of life years later, including a reduction in rehabilitation abilities, work 
performance, and financial obligations (Van Dijk et al., 2002). 
Reducing the Risks of Cardiopulmonary Bypass 
 The very first successful cardiac surgery using the cardiopulmonary bypass was in 
May of 1953 by its inventor Dr. John H. Gibbon. Although the machine helped to save 
lives, many patients died because of emboli; and many others who survived showed 
neurocognitive dysfunction after surgery. Components of the CPB such as the bubble 
oxygenator proved to be the cause of many of the complications such as emboli 
(Edmunds, 2003).  
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 Since that first successful use of the heart-lung machine, there have been many 
advances in CPB. Each new change or addition to the machine has been in attempt to 
reduce the risks that are described above and to ultimately save lives. Because the 
patient’s blood is introduced into an entirely new environment, no matter how close the 
machine is to the human’s natural setting, there will always be some type of 
physiological reaction. “But in reality 50 years after the first successful use of the heart-
lung machine and the extension of millions of lives, blood and the heart-lung machine 
remain incompatible” (Edmunds, 2003, p. 2223). Ways to increase compatibility and 
reduce these risks such as inflammation, microemboli, and heart and lung complications 
will be discussed here. 
Membrane Oxygenators 
 Throughout the years, the CPB machine has made several changes in order to 
have better outcomes and save more lives without adverse effects. One such change is the 
use of a membrane oxygenator instead of a bubble oxygenator. As stated earlier, bubble 
oxygenators were once used to oxygenate the blood and collect carbon dioxide to be 
carried out of the body. However, bubble oxygenators may be allowing more 
microemboli to escape into the body and possibly the brain (Edmunds, 2003).  
Although both the membrane and bubble oxygenators perform the same job, they 
do it through different means. The membrane oxygenator is either made of a microporous 
membrane or sheaves of hollow fibers that spreads blood out so that carbon dioxide and 
oxygen can be diffused. A bubble oxygenator differs in that carbon dioxide and oxygen 
are diffused around actual small bubbles. Although the bubbles produced increase the 
surface area for gas exchange, membrane oxygenators have been proven to produce less 
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microemboli, are less reactive to blood elements, and allow for better control of blood 
gases (Hessel & Edmunds, 2003). 
One study in 1987 compared the microemboli produced when using the two types 
of oxygenators. The ten patients that used membrane oxygenators as well as an arterial 
line filter had zero microemboli. This varies greatly with those that used bubble 
oxygenators. Each of these 17 patients had between 4 and 39 microemboli detected by a 
Doppler ultrasound (Padayachee et al., 1987).  
Heparin-Coated Circuits 
Another method that is often used to reduce risks of CPB is the use of heparin-
bonded circuits. Heparin is an anticoagulant drug that blocks the conversion of 
prothrombin to thrombin to prevent new clot formation (Hodgson & Kizior, 2009). While 
reducing clot formation was the original use for heparin-coated circuits, other positive 
benefits have been identified. Although difficult to prove clinically, heparin has some 
anti-inflammatory benefits; and studies show that the drug helps other portions of the 
body such as the lungs and heart and can reduce hospital stay (de Vroege, Huybregts, van 
Oeveren, van Klarenbosch, Linley, et al., 2005; Jessen, 2006; Mangoush et al., 2007). 
Since the systemic inflammatory response can be so damaging to the body after 
CPB, understanding why it occurs and how it can be reduced is vital. Once blood comes 
in contact with the CPB machine, the body generally begins to defend itself with the use 
of defense mechanisms such as complements, interleukins, and cytokines. If these 
proinflammatory mediators cannot be controlled by antiinflammatory mediators, 
systemic inflammation will occur. These mediators lead to widespread vasodilation and 
increased vascular permeability, allowing fluid to seep into the body’s tissues. 
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Endothelial damage also occurs, as well as increased heart rate and fever. The production 
of the cytokine tumor necrosis factor also produces thrombin which assists in the body’s 
coagulation. This factor coupled with endothelial damage caused by proinflammatory 
mediators increases the body’s risk of developing thrombi throughout the vascular system 
(Laffey et al., 2002). 
Although it is not entirely known how they work, heparin-coated circuits are of 
some benefit in reducing this inflammatory response. In one study, 51 patients 
undergoing a coronary artery bypass graft were separated into those who would get a 
heparin-coated circuit and those whose circuit would be uncoated. After two hours in the 
intensive care after surgery, those patients with heparin-bonded circuits had significantly 
lower leukocyte counts. They also had lower concentrations of the complement C3b/c in 
their blood, indicating that their inflammatory response did not activate as many 
complements because of the heparin (de Vroege et al., 2005). One analysis of other 
studies found that heparin-coating inhibits contact activation and reduces complement 
activation (Mangoush et al., 2007). Another found that using heparin decreased 
complement activation, suppressed leukocyte activation, and decreased release of 
cytokines (Jessen, 2006).   
Mainly due to the decrease in inflammation, heparin-coated circuits help to 
improve lung function following surgery. Inflammation causes an increase in capillary 
permeability and thus fluid buildup. When this inflammation occurs in the lungs, as it 
will with SIRS, pulmonary edema and decreased function often occurs. During the same 
study, de Vroege researched pulmonary function in heparin and non-heparin coated 
circuits. The non-heparin coated circuits demonstrated increased pulmonary shunt 
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fraction, decreased Pao2/FiO2 ratio, and increased pulmonary vascular resistance index. 
Each of these pulmonary indices indicates a decrease in pulmonary function (de Vroege 
et al., 2004). 
 Heparin-coated circuits reduce the need for blood transfusions and the occurrence 
of re-sternotomy after surgery. The drug also decreases the duration of ventilation and the 
patient’s length of stay in the hospital (Mangoush et al., 2007). Another study comparing 
heparin-coated and non heparin-coated circuits showed that non heparin-coated circuits 
had an increased level of bradykinin (causes vasodilation and therefore decreased blood 
pressure) and an increase in creatine kinase. An increased level in this indicates an injury 
to either the heart, brain, or skeletal muscle (de Vroege et al., 2005).  
Ultrafiltration 
 Ultrafiltration is a widely used process in pediatric cardiac surgery but has not yet 
been generally accepted for adult surgery. Research has shown that this procedure may be 
beneficial in adults as well as children. Ultrafiltration is a practice whereby the patient’s 
blood is passed through a filter with tiny pores. Pressure throughout the filter pushes 
excess solutes and fluid out and then the blood is returned to the body. Two main types of 
ultrafiltration exist: conventional and modified. Conventional ultrafiltration is completed 
during CPB only, and not after it is discontinued. The blood is taken from the venous 
reservoir and replaced into the oxygenator. Modified ultrafiltration, on the other hand, is 
run after CPB is completed. Blood during this type is taken from a sideport in the aortic 
cannula into a hemofilter and returned to the right atrium. These processes cause a 
decrease in plasma volume, leading to an increase in concentration of red blood cells. 
This increased concentration requires that the blood be returned with crystalloid solutions 
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to prevent hypovolemia. Hopefully, through this process, not only are excess solutes and 
volume removed, but inflammatory mediators as well, thereby decreasing the 
inflammatory response (Boodhwani et al., 2006). 
 A study, although on pediatric patients, found that ultrafiltration does in fact 
reduce the inflammatory response as well as help pulmonary function (Huang et al., 
2003). This study used a combination of modified ultrafiltration and balanced 
ultrafiltration, calling it continuous ultrafiltration. The article indicated that balanced 
ultrafiltration is similar to conventional in that it runs throughout the course of CPB and 
removes harmful solutes. Using this type of ultrafiltration, the tested group had much 
lower levels of the inflammatory mediator IL-6. This group also had lower levels of 
thromboxane b2, a metabolite of thromboxane A2 that deals with platelet aggregation. A 
higher serum hematocrit and albumin level was also noted in the ultrafiltration group. 
The authors attributed the increased serum concentration and decrease in inflammatory 
mediators to be the cause of the pulmonary preservation. The treated group had increased 
pulmonary compliance and decreased airway resistance and improved gas exchange as 
evidenced by decreased alveolar-arterial oxygen difference. The authors concluded that 
using ultrafiltration is a very beneficial choice during CPB (Huang et al., 2003). 
 Another study of ultrafiltration on adults showed extremely positive outcomes for 
the patients as well. Using combined conventional and modified ultrafiltration, patients 
showed higher hemoglobin, hematocrit, and platelet levels. Hemodynamically, patients 
treated with ultrafiltration also had increased mean arterial pressure and cardiac index. 
The alveolar-arterial PO2 gradient was also decreased in this study, showing pulmonary 
improvement (Kiziltepe et al., 2001). A meta-analysis looking at the effects of 
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ultrafiltration showed a decrease in postoperative bleeding by 70ml/patient and a 
decrease in the need for blood products by 0.7units/patient. Modified ultrafiltration 
showed the greatest benefit in this analysis (Boodhwani et al., 2006).  
Corticosteroids 
 Corticosteroids are drugs with the primary purposes of preventing and 
suppressing immune responses and decreasing the inflammatory response (Hodgson & 
Kizior, 2009). Their use with cardiopulmonary bypass has been controversial. On one 
hand, they have the potential to reduce inflammation, but steroids also have the potential 
to reduce the patient’s immune system so much that they become even more susceptible 
to infection and wounds. Although debate exists on the use of these drugs during CPB, 
several studies have shown benefits to using them (Halonen et al, 2007; Whitlock et al., 
2006). 
 Knowing that using steroids in excess may cause more adverse effects, one study 
researched using low doses of these throughout the procedure. Pulsing low-dose 
methylprednisolone, a type of adrenal corticosteroid, during CPB proved to be beneficial 
compared with a group that received a placebo (Whitlock et al., 2006). Those that 
received steroids had lower levels of IL-6, less blood loss, higher mean arterial pressure 
(MAP), less incidence of onset of atrial fibrillation, and shorter length of intubation when 
compared with the placebo group (Whitlock et al., 2006). Another study concluded that 
corticosteroids were successful in decreasing the incidence of postoperative atrial 
fibrillation, the most commonly developed cardiac dysrhythmia following surgery. Using 
hydrocortisone, the incidence of atrial fibrillation was 30% as opposed to 48% in the 
placebo group (Halonen et al, 2007). These studies indicate that corticosteroid therapy 
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during cardiac surgery and CPB can prevent issues such as atrial fibrillation, but may also 
improve other adverse effects such as inflammation and blood loss (Halonen et al, 2007; 
Whitlock et al., 2006). 
Conclusion 
 Cardiac surgery has certainly advanced over the years, particularly with the 
development of the cardiopulmonary bypass machine. Being able to operate on a 
completely motionless heart is an incredible progression that may help save many lives. 
The CPB machine itself has come a long way in development since the first surgery and 
will continue to develop to enhance every patient’s quality of life. 
 Although the CPB is an amazing machine, many adverse effects can occur. A 
systemic inflammatory response is the most common due to the blood being introduced 
to an entirely new environment. This inflammatory response can lead to many other 
problems throughout the body and ultimately organ failure may occur. Other adverse 
effects are atrial fibrillation, pulmonary damage including edema and ischemia, renal 
failure, and neurocognitive deficits. While some of these are not common effects, 
research has shown that they certainly are possible and harmful. 
 The goal of any surgery, in particular cardiac surgery, is to fix the previous 
problem and prevent adverse effects. Preventing these adverse effects is an ongoing 
process and will continue to be so. Using membrane oxygenators and adding filters 
throughout the machine have been useful in preventing microemboli from travelling 
throughout the body. Research has shown that coating the circuit with heparin may 
reduce inflammation, bleeding, the need for blood transfusions, and pulmonary injury. 
Ultrafiltration is being studied and found to reduce inflammation and pulmonary harm as 
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well. Medications such as corticosteroids are also identified to be beneficial in reducing 
cardiac complications and reducing the inflammatory response. It is the hope of all 
healthcare professionals that the incidence of harmful consequences of cardiopulmonary 
bypass will continue to decline and someday the risks associated will be close to zero. 
Until that day, research will continue and new methods will be tested to improve this 
already incredible machine. 
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